Related Experiment Videos
Hypertension in elders. Clinical diagnosis and treatment considerations
Insights
Isolated systolic hypertension (ISH) is common in older adults and can be treated with medication. However, evidence for reducing long-term risks is limited, requiring individualized treatment plans.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Pharmacology
Background:
- Isolated systolic hypertension (ISH) affects over 50% of individuals aged 65 and older.
- ISH is associated with increased risks of illness and death.
Purpose of the Study:
- To review the treatment of ISH in the elderly population.
- To highlight the need for individualized treatment strategies.
Main Methods:
- Literature review of studies on ISH treatment in older adults.
- Analysis of the benefits and risks of antihypertensive medications.
Main Results:
- Antihypertensive medications are effective in lowering ISH.
- Limited evidence exists on the long-term benefits of ISH treatment on morbidity and mortality in diverse elderly populations.
Conclusions:
- Treatment decisions for ISH in the elderly require balancing the risks of the condition against potential treatment side effects and impact on quality of life.
- Individualized care planning is essential for managing ISH in older adults.
Abstract:
Isolated systolic hypertension (ISH) accounts for more than 50% of all hypertension in persons over age 65 and is linked to increased morbidity and mortality. The various antihypertensive medications have been shown to be effective in reducing ISH. However, the efficacy of such treatment in reducing morbidity and mortality has been demonstrated in only one study to date and only on a selected population. The care provider for an elderly person with ISH must therefore weigh the risks of ISH against the risks of treatment of side effects and quality of life. Ultimately, the treatment of ISH in those over age 65 must be carefully planned on an individual basis.